Effect of hamster liver passage on the isoenzyme patterns of Entamoeba histolytica

X J Cheng1, M Y Huang, D Mirelman

  • 1Department of Parasitology, Shanghai Medical University.

Chinese Medical Journal
|November 1, 1992
PubMed

Insights

Entamoeba histolytica isoenzyme patterns changed after hamster liver passage, shifting from non-pathogenic to pathogenic types. This study shows that isoenzyme profiles are not stable characteristics of this parasite.

Area of Science:

  • Medical Parasitology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Entamoeba histolytica is a protozoan parasite causing amoebiasis.
  • Isoenzyme analysis (zymodeme analysis) is used to differentiate strains.
  • Virulence of E. histolytica can vary significantly.

Purpose of the Study:

  • To investigate the effect of host passage on the isoenzyme patterns of Entamoeba histolytica.
  • To determine if virulence is associated with specific zymodemes.
  • To assess the stability of isoenzyme profiles in E. histolytica.

Main Methods:

  • Cultivation of E. histolytica isolates in axenic culture.
  • Determination of isoenzyme patterns (zymodemes) for hexokinase (HK), phosphoglucomutase (PGM), and glucose phosphoisomerase (GPI).
  • Inoculation of trophozoites into hamster livers, followed by recovery and re-analysis of isoenzyme patterns and virulence assessment.

Main Results:

  • Initially, E. histolytica isolates belonged to non-pathogenic zymodeme group X, with one showing intermediate characteristics.
  • After hamster liver passage, all isolates shifted to pathogenic zymodeme type XIV.
  • Liver passage enhanced virulence, indicated by increased leukocyte destruction.

Conclusions:

  • Host passage, specifically in the hamster liver, can alter the isoenzyme patterns of Entamoeba histolytica.
  • Isoenzyme profiles are not stable and can change following adaptation to a host environment.
  • Changes in zymodeme may correlate with increased parasitic virulence.

Related Concept Videos

Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...